Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Insights into the biology and therapeutic implications of TNF and regulatory T cells
Benoı̂t L. Salomon
Nature Reviews Rheumatology (2021) Vol. 17, Iss. 8, pp. 487-504
Open Access | Times Cited: 74

Showing 1-25 of 74 citing articles:

Metabolic Messengers: tumour necrosis factor
Jaswinder K. Sethi, Gökhan S. Hotamışlıgil
Nature Metabolism (2021) Vol. 3, Iss. 10, pp. 1302-1312
Open Access | Times Cited: 292
TNF in the liver: targeting a central player in inflammation
Gisa Tiegs, Andrea Kristina Horst
Seminars in Immunopathology (2022) Vol. 44, Iss. 4, pp. 445-459
Open Access | Times Cited: 117
Targeted Immunotherapy for Autoimmune Disease
Seung Min Jung, Wan‐Uk Kim
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 109
Immunosuppression for immune-related adverse events during checkpoint inhibition: an intricate balance
Rik J. Verheijden, Mick J M van Eijs, Anne M. May, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 53
TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond
Daniela Siegmund, Harald Wajant
Nature Reviews Rheumatology (2023) Vol. 19, Iss. 9, pp. 576-591
Closed Access | Times Cited: 43
Understanding Autoimmunity: Mechanisms, Predisposing Factors, and Cytokine Therapies
Farzana Yasmeen, Rameez Hassan Pirzada, Bilal Ahmad, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7666-7666
Open Access | Times Cited: 19
Fourth-generation chimeric antigen receptor T-cell therapy is tolerable and efficacious in treatment-resistant rheumatoid arthritis
Yujing Li, Sujun Li, Xiaojuan Zhao, et al.
Cell Research (2025)
Open Access | Times Cited: 2
Oral Nanomotor‐Enabled Mucus Traverse and Tumor Penetration for Targeted Chemo‐Sono‐Immunotherapy against Colon Cancer
Yingui Cao, Shengsheng Liu, Ya Ma, et al.
Small (2022) Vol. 18, Iss. 42
Closed Access | Times Cited: 61
Single-Cell Transcriptome Analysis of Chronic Antibody-Mediated Rejection After Renal Transplantation
Fanhua Kong, Shaojun Ye, Zibiao Zhong, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 32
Cytokines in the Immune Microenvironment Change the Glycosylation of IgG by Regulating Intracellular Glycosyltransferases
Yedi Cao, Zhijing Song, Zhendong Guo, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 32
Regulatory T cells in autoimmune kidney diseases and transplantation
Norihisa Mikami, Shimon Sakaguchi
Nature Reviews Nephrology (2023) Vol. 19, Iss. 9, pp. 544-557
Closed Access | Times Cited: 20
Tackling TNF-α in autoinflammatory disorders and autoimmune diseases: From conventional to cutting edge in biologics and RNA- based nanomedicines
Valentina Andretto, Silvia Dusi, Serena Zilio, et al.
Advanced Drug Delivery Reviews (2023) Vol. 201, pp. 115080-115080
Closed Access | Times Cited: 18
Atrazine promotes breast cancer development by suppressing immune function and upregulating MMP expression
Mengqi Wang, Junyu Chen, Shuhua Zhao, et al.
Ecotoxicology and Environmental Safety (2023) Vol. 253, pp. 114691-114691
Open Access | Times Cited: 17
DNA Nanostructures Treat Inflammatory Bowel Disease through ROS Scavenging and Gut Microbiota Modulation
Jingru Ge, Bin Jia, Yuang Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 38
Closed Access | Times Cited: 7
Simplified α2-macroglobulin as a TNF-α inhibitor for inflammation alleviation in osteoarthritis and myocardial infarction therapy
Weiwei Zheng, Tong Zhou, Yuxiang Zhang, et al.
Biomaterials (2023) Vol. 301, pp. 122247-122247
Closed Access | Times Cited: 16
The diversified hydrogels for biomedical applications and their imperative roles in tissue regeneration
Xinhui Wang, Yuan Ma, Feng Lu, et al.
Biomaterials Science (2023) Vol. 11, Iss. 8, pp. 2639-2660
Closed Access | Times Cited: 15
MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway
Cheng Zhou, Bao‐Ye Sun, Pei‐Yun Zhou, et al.
Clinical Immunology (2023) Vol. 256, pp. 109770-109770
Closed Access | Times Cited: 14
Neutrophil-intrinsic TNF receptor signaling orchestrates host defense against Staphylococcus aureus
Christine Youn, Cristina Pontaza, Yu Wang, et al.
Science Advances (2023) Vol. 9, Iss. 24
Open Access | Times Cited: 13
Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms
Yijun Wu, Xu Sun, Kai Kang, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 5
Targeted therapy for autoimmune diseases based on multifunctional frame nucleic acid system: Blocking TNF-α-NF-κB signaling and mediating macrophage polarization
Mei Zhang, Yuting Wen, Zhangheng Huang, et al.
Chemical Engineering Journal (2022) Vol. 454, pp. 140399-140399
Closed Access | Times Cited: 22
Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases
Jun Liu, Hui Zhang, Yanhong Su, et al.
Cell & Bioscience (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 21
An orally available small molecule that targets soluble TNF to deliver anti-TNF biologic-like efficacy in rheumatoid arthritis
Alexander Vugler, James P. O’Connell, Mai Ánh Nguyễn, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
A DNA-polymer hybrid nanocomplex based bi-adjuvant vaccine for tumor immunotherapy
Feng Li, Xiaohui Ding, Zhaoyue Lv, et al.
Nano Today (2023) Vol. 54, pp. 102061-102061
Closed Access | Times Cited: 12
Treg-based immunotherapy for antigen-specific immune suppression and stable tolerance induction: a perspective
Shimon Sakaguchi, Ryoji Kawakami, Norihisa Mikami
Immunotherapy Advances (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 11
The key role of inflammation in the pathogenesis and management of obesity and CVD
Chrysoula Boutari, Michael A. Hill, Claudio Procaccini, et al.
Metabolism (2023) Vol. 145, pp. 155627-155627
Closed Access | Times Cited: 11
Page 1 - Next Page

Scroll to top